A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes

Journal of Clinical Investigation

Volumn 85, Issue 5, 1990, Pages 1686-1693

  Shellito, Judd ^a,b,c,d   Suzara, Vincent V ^a   Blumenfeld, Walter ^a,c   Beck, James M ^a,b   Steger, Harold J ^a   Ermak, Thomas H ^a,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Pneumocystis carinii immunosuppression; Pneumonia

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HELPER CELL; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROTOZOON;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PNEUMONIA, PNEUMOCYSTIS CARINII; SPLEEN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, HELPER-INDUCER; THYMUS GLAND;

EID: 0025282012     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI114621     Document Type: Article

References (49)

1. Walzer, P., D. Krogstad, and P. Rawson. 1974. Pneumocystis carinii pneumonia in the United States: epidemiologic, clinical, and diagnostic features. Ann. Intern. Med. 80:83-93.
2. 1986. Update: acquired immunodeficiency syndrome (AIDS)-United States. MMWR (Morbid. Mortal Week. Rep.). 35:17-21.
3. Wachter, R., J. Luce, J. Turner, P. Volberding, and P. Hopewell. 1986. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing patterns of utilization. Am. Rev. Respir. Dis. 134:796-799.
4. Wharton, J., D. Coleman, C. Wofsy, J. Luce, W. Blumenfeld, W. Hadley, L. Ingram, P. Volberding, and P. Hopewell. 1986. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:37-44.
5. Blumenfeld, W., and J. Griffiss. 1989. In vitro differentiation of human-derived Pneumocystis carinii. J. Clin. Microbiol. 27:480-485.
6. Cushion, M., J. Ruffolo, and P. Walzer. 1988. Analysis of the developmental stages of Pneumocystis carinii in vitro. Lab. Invest. 58:324-331.
7. Bartlett, M., P. Verbanac, and J. Smith. 1979. Cultivation of Pneumocystis carinii with Wl-38 cells. J. Clin. Microbiol. 10:796-799.
8. Walzer, P., V. Schnelle, D. Armstrong, and P. Rosen. 1977. Nude mouse: a new experimental model for Pneumocystis carinii infection. Science (Wash. DC). 197:177-179.
9. Walzer, P., C. Kim, M. Linke, C. Pogue, M. Huerkamp, C. Chrisp, A. Lerro, S. Wixson, E. Hall, and L. Shultz. 1989. Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice. Infect. Immun. 57:62-70.
10. Frenkel, J., J. Good, and J. Schultz. 1966. Latent Pneumocystis infections of rats, relapse, and chemotherapy. Lab. Invest. 15:1559-1577.
11. Fauci, A., A. Macher, D. Longo, H. Lane, A. Rook, J. Masur, and E. Gelmann. 1984. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann. Intern. Med. 100:92-106.
12. Dialynas, D., Z. Quan, K. Wall, A. Pierres, J. Quintans, M. Loken, M. Pierres, and F. Fitch. 1983. Characterization of the murine T cell surface molecule designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445-2449.
13. - T cells: amplification in spleens of mice following in vivo treatment with monoclonal antibody anti-L3T4. Eur. J. Immunol. 18:231-235.
14. Wofsy, D., D. Mayes, J. Woodcock, and L. Seamna. 1985. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. J. Immunol. 135:1698-1701.
15. Titus, R., R. Ceredig, J. Cerottini, and J. Louis. 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol. 135:2108-2114.
16. Heyworth, M., J. Carlson, and T. Ermak. 1987. Clearance of Giardia muris infection requires helper/inducer T lymphocytes. J. Exp. Med. 165:1743-1748.
17. Minoprio, P., H. Eisen, M. Joskowicz, P. Pereira, and A. Coutinho. 1987. Suppression of polyclonal antibody production in Trypanosorna cruzi-infected mice by treatment with anti-L3T4 antibodies. J. Immunol. 139:545-550.
18. Gomez, A., W. Bullock, C. Taylor, and G. J. Deepe. 1988. Role of L3T4+ cells in host defense against Histoplasma capsulatum. Infect. Immun. 56:1685-1691.
19. Wofsy, D., and W. Seaman. 1985. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378-391.
20. Fowlkes, B., R. Schwartz, and D. Pardoll. 1988. Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage. Nature (Lond.). 334:620-623.
21. McCarthy, S., A. Kruisbeek, I. Uppenkamp, S. Sharrow, and A. Singer. 1988. Engagement of the CD4 molecule influences cell surface expression of the T-cell receptor on thymocytes. Nature (Lond.). 336:76-79.
22. Wofsy, D., N. Chiang, J. Greenspan, and T. Ermak. 1988. Treatment of murine lupus with monoclonal antibody to L3T4. I. Effects on the distribution and function of lymphocyte subsets and on the histopathology of autoimmune disease. J. Autoimmun. 1:415-431.
23. Gutstein, N., and D. Wofsy. 1986. Administration of F(ab)2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells. J. Immunol. 137:3414-3419.
24. McLeod, E., J. Caldwell, and H. Kaltreider. 1978. Pulmonary immune responses of inbred mice: appearance of antibody-forming cells in C57BL/6 mice after intrapulmonary or systemic immunization with sheep erythrocytes. Am. Rev. Respir. Dis. 118:561-571.
25. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21(Suppl):77-89.
26. Ledbetter, J., R. Rouse, H. Micklem, and L. Herzenberg. 1980. T cell subsets denned by the expression of Lyt-1,2,3 and Thy-1 antigens. Two parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J. Exp. Med. 152:280-291.
27. Lanier, L., G. Gutman, D. Lewis, S. Griswold, and N. Warner. 1982. Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma. 1:125-132.
28. Scollay, R., P. Barlett, and K. Shortman. 1984. T cell development in the adult murine thymus: changes in the expression of the surface antigens Ly2, L3T4, and B2A2 during development from early precursor cells to emigrants. Immunol. Rev. 82:79-103.
29. Lanier, L., J. Allison, and J. Phillips. 1986. Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation. J. Immunol. 137:2051-2057.
30. Kim, C., J. Foy, M. Cushion, D. Stanforth, M. Linke, H. Hendrix, and P. Walzer. 1987. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocyslis carinii pneumonia. Antimicrob. Agents Chemother. 31:197-201.
31. Hughes, W., and B. Smith. 1984. Efficacy of diamino-diphenylsulfone and other drugs in murine Pneumocystis carinii pneumonias. Antimicrob. Agents Chemother. 26:436-440.
32. Debs, R., W. Blumenfeld, E. Brunette, R. Straubinger, A. Montgomery, E. Lin, N. Agabian, and D. Papahadjopoulos. 1987. Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob. Agents Chemother. 31:37-41.
33. Zar, J. 1974. Biostatistical Analysis. Prentice-Hall, Inc., Englewood Cliffs, NJ. 130-150.
34. Walzer, P. 1984. Experimental models of Pneumocystis carinii infections. In Pneumocystis carinii Pneumonia: Pathogenesis, Diagnosis, and Treatment. L. Young, editor. Marcel Dekker, Inc., New York. 7-76.
35. Bartlett, M., J. Fishman, S. Queener, M. Durkin, M. Jay, and J. Smith. 1988. New rat model of Pneumocystis carinii infection. J. Clin. Microbiol. 26:1100-1102.
36. Eisen, S. 1989. Decreased yield of Pneumocystis carinii from cortisonized rats. J. Parasitol. 75:82-85.
37. Bartlett, M., M. Durkin, M. Jay, S. Queener, and J. Smith. 1987. Sources of rats free of latent Pneumocystis carinii. J. Clin. Microbiol. 25:1794-1795.
38. Cupps, T., and A. Fauci. 1982. Corticosteroid-mediated immunoregulation in man. Immunol Rev. 65:133-155.
39. Shultz, L., and C. Sidman. 1987. Genetically determined murine models of immunodeficiency. Annu. Rev. Immunol. 5:367-403.
40. Graves, D. 1989. Immunological studies of Pneumocystis carinii. J. Protozool. 36:60-69.
41. Crocker, P., W. Jefferies, S. Clark, L. Chung, and S. Gordon. 1987. Species heterogeneity in macrophage expression of the CD4 antigen. J. Exp. Med. 166:613-618.
42. Hughes, W., and B. Smith. 1982. Provocation of infection due to Pneumocystis carinii by cyclosporin A. J. Infect. Dis. 145:767.
43. Von Behren, L., and E. Pesanti. 1978. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am. Rev. Respir. Dis. 118:1051-1059.
44. Pesanti, E. 1982. Effects of bacterial pneumonitis on development of pneumocystosis in rats. Am. Rev. Respir. Dis. 125:723-728.
45. Pesanti, E. 1987. Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells. Inject. Immun. 55:736-741.
46. Long, E., J. Smith, and J. Meier. 1986. Attachment of Pneumocystis carinii to rat pneumocytes. Lab. Invest. 54:609-615.
47. Walzer, P. 1986. Attachment of microbes to host cells: relevance of Pneumocystis carinii. Lab. Invest. 54:589-592.
48. Ognibene, F., H. Masur, P. Rogers, W. Travis, A. Suffredini, I. Feuerstein, V. Gill, B. Baird, J. Carrasquillo, J. Parillo, H. Lane, and J. Shelhamer. 1988. Human immunodeficiency virus infected individuals with no pulmonary symptoms often have evidence of nonspecific interstitial pneumonitis but not Pneumocystis carinii at bronchoscopy. Ann. Intern. Med. 104:874-879.
49. Coleman, D., J. Luce, J. Wilbur. J. Ferrer, B, Stephens, W. Margaretten, E. Wagar, W. Hadley, L. Pifer, and A. Moss. 1986. Antibody to the retrovirus associated with the acquired immunodeficiency syndrome (AIDS): presence in presumably healthy San Franciscans who died unexpectedly. Arch. Intern. Med. 146:713-715.